Y. Tse, U. Udayaraj, Rishi Pruthi, A. Casula, Catriona Shaw, R. Steenkamp, A. Davenport, Anirudh Rao, J. Gilg, A. Williams, D. Pitcher, Catherine O’Brien, F. Braddon, Malcolm A. Lewis, H. Maxwell, J. Stojanovic, D. Fogarty, I. Macphee, R. Hilton, L. Pankhurst, N. Mamode, A. Hudson, P. Roderick, R. Ravanan, C. Inward, M. Sinha, T. Feest, Victoria R Briggs, R. Fluck, M. Wilkie, L. Crowley, Jennie Wilson, R. Guy, F. Caskey, K. Farrington, J. Nicholas, A. Dawnay, Satz Mengensatzproduktion, Werner Druck Medien Ag
{"title":"UK Renal Registry 16th Annual Report: Appendix B Definitions and Analysis Criteria","authors":"Y. Tse, U. Udayaraj, Rishi Pruthi, A. Casula, Catriona Shaw, R. Steenkamp, A. Davenport, Anirudh Rao, J. Gilg, A. Williams, D. Pitcher, Catherine O’Brien, F. Braddon, Malcolm A. Lewis, H. Maxwell, J. Stojanovic, D. Fogarty, I. Macphee, R. Hilton, L. Pankhurst, N. Mamode, A. Hudson, P. Roderick, R. Ravanan, C. Inward, M. Sinha, T. Feest, Victoria R Briggs, R. Fluck, M. Wilkie, L. Crowley, Jennie Wilson, R. Guy, F. Caskey, K. Farrington, J. Nicholas, A. Dawnay, Satz Mengensatzproduktion, Werner Druck Medien Ag","doi":"10.1159/000360036","DOIUrl":null,"url":null,"abstract":"The take-on population is defined as all patients over 18 who started RRT at UK renal centres and did not have a recovery lasting more than 90 days within 90 days of starting RRT. The treatment timeline is used to define take-on patients as follows. If a patient has timeline entries from more than one centre then these are all combined and sorted by date. Then, the first treatment entry gives the first date of when they were receiving RRT. This is defined as a ‘start date’. However, in the following situations there is evidence that the patient was already receiving RRT before this ‘start date’ and these people are not classed as take-on patients:","PeriodicalId":19094,"journal":{"name":"Nephron Clinical Practice","volume":"125 1","pages":"315 - 318"},"PeriodicalIF":0.0000,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000360036","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephron Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000360036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The take-on population is defined as all patients over 18 who started RRT at UK renal centres and did not have a recovery lasting more than 90 days within 90 days of starting RRT. The treatment timeline is used to define take-on patients as follows. If a patient has timeline entries from more than one centre then these are all combined and sorted by date. Then, the first treatment entry gives the first date of when they were receiving RRT. This is defined as a ‘start date’. However, in the following situations there is evidence that the patient was already receiving RRT before this ‘start date’ and these people are not classed as take-on patients: